HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F Ossendorp Selected Research

HLA-B61 antigen

10/2006BCR-ABL fusion regions as a source of multiple leukemia-specific CD8+ T-cell epitopes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


F Ossendorp Research Topics

Disease

9Neoplasms (Cancer)
11/2019 - 01/2000
2Lymphoma (Lymphomas)
11/2019 - 07/2000
2Carcinoma (Carcinomatosis)
11/2019 - 01/2001
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2007
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2006
1Leukemia
10/2006
1Communicable Diseases (Infectious Diseases)
12/2001
1Tuberculosis (Tuberculoses)
12/2001
1Melanoma (Melanoma, Malignant)
01/2001
1Renal Cell Carcinoma (Grawitz Tumor)
01/2001
1T-Cell Lymphoma (Lymphoma, T Cell)
07/2000

Drug/Important Bio-Agent (IBA)

6EpitopesIBA
10/2006 - 02/2000
5Peptides (Polypeptides)IBA
11/2019 - 07/2000
2VaccinesIBA
10/2006 - 11/2000
2AntigensIBA
01/2001 - 10/2000
1Poly I-CIBA
11/2019
1Cancer VaccinesIBA
11/2019
1Insulin (Novolin)FDA Link
04/2007
1HLA-B61 antigenIBA
10/2006
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
10/2006
1Subunit VaccinesIBA
12/2001
1HLA-A*02:01 antigenIBA
01/2001
1invariant chain (Ii-Key)IBA
11/2000
1Proteasome Endopeptidase Complex (Proteasome)IBA
02/2000

Therapy/Procedure

5Immunotherapy
11/2019 - 01/2000